1.47
price down icon2.65%   -0.04
pre-market  プレマーケット:  1.47  
loading
前日終値:
$1.51
開ける:
$1.5
24時間の取引高:
294.50K
Relative Volume:
0.31
時価総額:
$105.77M
収益:
-
当期純損益:
$-292.19M
株価収益率:
-0.3238
EPS:
-4.54
ネットキャッシュフロー:
$-208.41M
1週間 パフォーマンス:
+2.08%
1か月 パフォーマンス:
+8.89%
6か月 パフォーマンス:
-33.78%
1年 パフォーマンス:
-65.89%
1日の値動き範囲:
Value
$1.46
$1.515
1週間の範囲:
Value
$1.375
$1.52
52週間の値動き範囲:
Value
$1.01
$5.44

Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile

Name
名前
Zentalis Pharmaceuticals Inc
Name
セクター
Healthcare (1161)
Name
電話
(858) 263-4333
Name
住所
10275 SCIENCE CENTER DRIVE, SAN DIEGO, NY
Name
職員
166
Name
Twitter
@ZentalisP
Name
次回の収益日
2025-03-26
Name
最新のSEC提出書
Name
ZNTL's Discussions on Twitter

ZNTL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ZNTL
Zentalis Pharmaceuticals Inc
1.47 102.89M 0 -292.19M -208.41M -4.54
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-12 アップグレード Wedbush Underperform → Neutral
2024-06-20 ダウングレード UBS Buy → Neutral
2024-06-18 ダウングレード Jefferies Buy → Hold
2024-06-18 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-06-18 ダウングレード Wedbush Neutral → Underperform
2024-06-18 ダウングレード Wells Fargo Overweight → Equal Weight
2023-11-08 ダウングレード Wedbush Outperform → Neutral
2023-11-07 ダウングレード Leerink Partners Outperform → Market Perform
2022-07-12 開始されました Cowen Outperform
2022-04-06 開始されました Wells Fargo Overweight
2021-10-07 再開されました Jefferies Buy
2021-09-30 開始されました Stifel Buy
2021-09-29 開始されました Oppenheimer Outperform
2021-05-21 開始されました UBS Buy
2021-01-20 開始されました Wedbush Outperform
2020-09-29 開始されました Cantor Fitzgerald Overweight
2020-08-27 開始されました H.C. Wainwright Buy
2020-04-28 開始されました Guggenheim Buy
2020-04-28 開始されました Jefferies Buy
2020-04-28 開始されました Morgan Stanley Overweight
2020-04-28 開始されました SVB Leerink Outperform
すべてを表示

Zentalis Pharmaceuticals Inc (ZNTL) 最新ニュース

pulisher
03:09 AM

What makes Zentalis Pharmaceuticals Inc. stock price move sharplyConsistent High Return Strategy - Newser

03:09 AM
pulisher
12:04 PM

What drives Zentalis Pharmaceuticals Inc. stock priceFree Technical Analysis Support - PrintWeekIndia

12:04 PM
pulisher
Jul 23, 2025

Is Zentalis Pharmaceuticals Inc. a good long term investmentFree Technical Analysis Support - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Zentalis Pharmaceuticals Inc. stockFree Stock Selection - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Zentalis Pharmaceuticals Inc. Stock Analysis and ForecastAccelerated capital growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 15, 2025

Why Zentalis Pharmaceuticals Inc. stock attracts strong analyst attentionPrecision Entry Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Zentalis Pharmaceuticals Inc. stock performs during market volatilityDaily Swing Candidates - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Insider Stock Buyers At Zentalis Pharmaceuticals Recouped Some Losses This Week - simplywall.st

Jul 14, 2025
pulisher
Jul 12, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Jul 12, 2025
pulisher
Jul 07, 2025

Wealth Enhancement Advisory Services LLC Purchases 33,958 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jul 07, 2025
pulisher
Jul 01, 2025

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - TradingView

Jul 01, 2025
pulisher
Jul 01, 2025

Zentalis Grants $1.19 Per Share Stock Options Package Under Nasdaq Compliance Rules - Stock Titan

Jul 01, 2025
pulisher
Jun 30, 2025

Zentalis Pharmaceuticals, Inc.(NasdaqGM:ZNTL) dropped from Russell Small Cap Completeness Index - MarketScreener

Jun 30, 2025
pulisher
Jun 18, 2025

Zentalis Pharmaceuticals shareholders elect three directors at annual meeting - Investing.com

Jun 18, 2025
pulisher
Jun 17, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Average Rating of “Hold” from Brokerages - Defense World

Jun 17, 2025
pulisher
Jun 12, 2025

Wealth Enhancement Advisory Services LLC Raises Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Shares Sold by Bank of America Corp DE - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Reduces Stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 09, 2025
pulisher
Jun 06, 2025

Ameriprise Financial Inc. Purchases New Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Zentalis Pharmaceuticals Announces Azenosertib Fast Track Designation and Virtual Corporate Event to Present Updated Data from Azenosertib Clinical Studies - The Globe and Mail

Jun 05, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Lowers Holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Why Did Zentalis Pharmaceuticals Inc. (ZNTL) Plunge 11.33%? - AInvest

Jun 05, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Has $1.94 Million Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Deutsche Bank AG Grows Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Two Sigma Investments LP Sells 291,801 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ZNTL Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

Zentalis Expands Cancer Research Team: 137K Share Options Granted to Key New Hires - Stock Titan

Jun 02, 2025
pulisher
Jun 02, 2025

Zentalis Pharmaceuticals Presents Promising Study Results at ASCO - TipRanks

Jun 02, 2025
pulisher
Jun 01, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Shares Acquired by Millennium Management LLC - Defense World

Jun 01, 2025
pulisher
May 28, 2025

Northern Trust Corp Raises Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

May 28, 2025
pulisher
May 25, 2025

BNP Paribas Financial Markets Invests $534,000 in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

May 25, 2025
pulisher
May 23, 2025

Captrust Financial Advisors Buys New Stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

May 23, 2025
pulisher
May 23, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Rating of “Hold” by Analysts - Defense World

May 23, 2025
pulisher
May 23, 2025

Jane Street Group LLC Boosts Stock Holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

May 23, 2025
pulisher
May 20, 2025

Zentalis Pharmaceuticals at H.C. Wainwright BioConnect Conference - TipRanks

May 20, 2025
pulisher
May 19, 2025

Balyasny Asset Management L.P. Has $175,000 Stock Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Wedbush Issues Optimistic Outlook for ZNTL Earnings - Defense World

May 19, 2025
pulisher
May 17, 2025

Wedbush Reaffirms Neutral Rating for Zentalis Pharmaceuticals (NASDAQ:ZNTL) - Defense World

May 17, 2025

Zentalis Pharmaceuticals Inc (ZNTL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Zentalis Pharmaceuticals Inc (ZNTL) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Bruns Ingmar
Chief Medical Officer
Feb 06 '25
Buy
2.28
20,000
45,656
36,629
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
大文字化:     |  ボリューム (24 時間):